PDCD1 and colon carcinoma: Similarly, the antitumor activity observed with anti-PD-1 mAb treatment in mouse colon carcinoma models shown here is not observed in human colorectal cancer patients except for patients with microsatellite unstable tumors [29] or mismatch repair deficient tumors [30].